Immunovant Inc (IMVT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMVT.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
IMVT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Immunovant Inc's upside potential (average analyst target price relative to current price) is higher than 90.5% of all US stocks.
- IMVT has a lower variance in analysts' estimates than 12.28% of all US stocks.
- IMVT has a greater number of analysts covering the stock than 87.24% of Pharmaceutical Products stocks.
- The average analyst price target of IMVT is higher than 70.33% of Pharmaceutical Products stocks.
- The NA of IMVT is higher than just about none of of all US stocks.
Is IMVT a Buy, Hold or Sell? See the POWR Ratings now!